Pediatric Pneumococcal Serotypes in 4 European Countries
- 1 September 2010
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (9), 1428-1439
- https://doi.org/10.3201/eid1609.100102
Abstract
After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain, Belgium, and England and Wales (United Kingdom), invasive disease from non-PCV7 serotypes (NVT) increased. Adjusted serotype-specific incidences among children <15 years of age were compared between 1999-2002 (prevaccine) and 2005-2006 (postmarketing). Vaccine coverage increased to approximate to 32%-48% in France, Spain, and Belgium but remained <1% in England and Wales. Serotype 1 incidence rose in all age groups and countries (incidence rate ratio [IRR] 1.3-4.2; p<0.004), independently of PCV7 use, but incidence of serotypes 7F and 19A increased most in France, Spain, and Belgium (IRR 1.9-16.9 in children <5 years; p<0.001), where PCV7 coverage was greater. Vaccine-induced replacement of PCV7 serotypes possibly contributed to NVT increases, as did secular trends. New vaccines targeting these serotypes are available, but serotype dynamics needs further exploration that accounts for underreporting and prevaccine trendsKeywords
This publication has 30 references indexed in Scilit:
- A dynamic model of pneumococcal infection in the United States: Implications for prevention through vaccinationVaccine, 2010
- Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007Journal of Clinical Microbiology, 2009
- Streptococcus pneumoniaeSerotype 19A in Children, South KoreaEmerging Infectious Diseases, 2008
- Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine eraJournal of Antimicrobial Chemotherapy, 2007
- Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996–2005Epidemiology and Infection, 2007
- Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccineFEMS Immunology & Medical Microbiology, 2007
- Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine: A Population-Based Case-Control StudyClinical Infectious Diseases, 2007
- Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine CoverageJAMA, 2007
- Impact of Pneumococcal Conjugate Vaccine and of Reduction of Antibiotic Use on Nasopharyngeal Carriage of Nonsusceptible Pneumococci in Children With Acute Otitis MediaThe Pediatric Infectious Disease Journal, 2006
- Invasive Pneumococcal Infections in Denmark from 1995 to 1999: Epidemiology, Serotypes, and ResistanceClinical and Vaccine Immunology, 2002